Contact information
amy.taylor@nds.ox.ac.uk
op.lead@nds.ox.ac.uk
https://orcid.org/0000-0002-8635-7953
She/her
Research groups
Amy Taylor
BSc (Hons) MSc (Res)
Operational Lead NDS SITU
I am an Operational Lead for NDS SITU, overseeing a portfolio of surgical clinical trials that cover areas as diverse as melanoma and brain tumours to chronic rhinosinusitis and upper GI surgery. I have worked in research at pre-clinical and clinical stages since 2002, developing extensive translational and transferable skills from each role.
As an operational lead for the unit, I am involved in the development of new grant applications, initial application and assessment stages and then oversee the set-up and implementation of the trial post-award. I provide ongoing management and guidance to trials at all stages, assisting the trial managers and clinical teams as needed. I am responsible for helping the trial managers meet their trial milestones and work closely with the trial CIs to ensure trials are delivered to a high standard.
Prior to this, I was Clinical Trial Manager for the FUTURE-GB trial (Functional and Ultrasound Guided Resection of Glioblastoma), in SITU(NDS). I have also worked in SITU (NDORMS) as a Clinical Trial Manager for NINJA - a large paediatric plastic surgery trial, and also on the feasibility study, SPINOUT-F.
I was a research coordinator for OxAAA, a large vascular study in NDS, and before that, worked in behavioural neuroscience research for 13 years across various Oxford University departments, gaining extensive experience in lab work, handling and analysis of large datasets and regulatory compliance processes. I obtained my MSc (Res) from the University of Oxford looking at the role of excitatory amino acid receptor subtypes in hippocampal-dependent learning and memory.
Recent publications
Preoperative Weight Loss in Patients With Excess Weight and Colorectal Cancer: The CARE Feasibility Randomized Clinical Trial.
Journal article
Koutoukidis DA. et al, (2025), JAMA Netw Open, 8
Prepectoral no mesh versus mesh immediate implant-based reconstruction after mastectomy (Restore-B): a multicentre single-blinded randomised controlled feasibility study protocol.
Journal article
Rolph R. et al, (2025), BMJ Open, 15
Protocol for the GOLF trial: randomized clinical trial on the LINX management system versus fundoplication for the surgical treatment of gastro-oesophageal reflux disease.
Journal article
Markar SR. et al, (2025), Br J Surg, 112
Local anaesthetic transperineal biopsy versus transrectal prostate biopsy in prostate cancer detection (TRANSLATE): a multicentre, randomised, controlled trial.
Journal article
Bryant RJ. et al, (2025), Lancet Oncol, 26, 583 - 595
Distinct effects of AMPAR subunit depletion on spatial memory.
Journal article
Eltokhi A. et al, (2023), iScience, 26
Protocol for open-label randomized clinical trial of intensive surveillance versus standard postoperative follow-up in patients undergoing surgical resection for oesophageal and gastric cancer.
Journal article
Markar SR. et al, (2023), Br J Surg, 110, 1359 - 1360